Contracts Finder · Award
Oncotype DX Breast Recurrence Score test
A public procurement published by Norfolk and Norwich University Hospitals NHS Foundation Trust via Contracts Finder.
- £583.2k
- Award value
- £340.2k
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
System for prognosis of breast cancer recurrence
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 85121200 — Medical specialist services
- Currency
- GBP
- Total award value
- £583,200
- Tender value
- £340,200
- First published
- 2 Apr 2024
- Last updated
- 2 Apr 2024
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Exact Sciences UK, Ltd. | 07484560 | 5 Mar 2024 | active | £583.2k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from Norfolk and Norwich University Hospitals NHS Foundation Trust
FAQs about this procurement
Who is the buyer for "Oncotype DX Breast Recurrence Score test"?
Oncotype DX Breast Recurrence Score test is a UK public-sector procurement published by Norfolk and Norwich University Hospitals NHS Foundation Trust via Contracts Finder.
Has "Oncotype DX Breast Recurrence Score test" been awarded?
Yes — 1 award is recorded, with a reported total value of £583,200. The current lifecycle stage is "Award".
Which suppliers are involved in "Oncotype DX Breast Recurrence Score test"?
1 supplier is linked: Exact Sciences UK, Ltd..
What is "Oncotype DX Breast Recurrence Score test" worth?
The reported award value is £583,200.
When was "Oncotype DX Breast Recurrence Score test" published?
It was first published on 2 Apr 2024 and last updated on 2 Apr 2024, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable